THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300771 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Elfira Amalia Deborah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Killer Cells, Natural, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
NK cells are cytotoxic innate lymphocytes that play a critical role in antitumor immunity. NK cells recognize target cells by using a repertoire of activating NK receptors and exert the effector functions. Although the magnitude of activation signals through activating NK receptors controls NK cell function, it has not been fully understood how these activating signals are modulated in NK cells. In this study, we found that a scaffold protein, THEMIS2, inhibits activating NK receptor signaling. Overexpression of THEMIS2 attenuated the effector function of human NK cells, whereas knockdown of THEMIS2 enhanced it. Mechanistically, THEMIS2 binds to GRB2 and phosphorylated SHP-1 and SHP-2 at the proximity of activating NK receptors DNAM-1 and NKG2D. Knockdown of THEMIS2 in primary human NK cells promoted the effector functions. Furthermore, Themis2-deficient mice showed low metastatic burden in an NK cell–dependent manner. These findings demonstrate that THEMIS2 has an inhibitory role in the antitumor activity of NK cells, suggesting that THEMIS2 might be a potential therapeutic target for NK cell–mediated cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Doctoral Program in Medical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Ibaraki, Japan.
- R&D Center for Innovative Drug Discovery, University of Tsukuba, Tsukuba, Ibaraki, Japan.
ORCID-Profile: Elfira Amalia Deborah, Tsukasa Nabekura, Kazuko Shibuya, Akira Shibuya
Zitieren
APA
Deborah, E. A., Nabekura, T., Shibuya, K., & Shibuya, A. (2024). THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300771
Vancouver
Deborah EA, Nabekura T, Shibuya K, Shibuya A. THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300771
BibTeX
@article{Deborah2024,
author = {Deborah, Elfira Amalia and Nabekura, Tsukasa and Shibuya, Kazuko and Shibuya, Akira},
title = {THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300771}
}
EUVIMED